Association between heme oxygenase-1 gene promoter polymorphisms and cancer susceptibility: A meta-analysis

被引:6
作者
Wang, Rui [1 ]
Shen, Jun [2 ]
Yang, Rui [3 ]
Wang, Wan-Guo [3 ]
Yuan, Ye [3 ]
Guo, Zhong-Hua [3 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Nephrol, Wuhan 430060, Hubei, Peoples R China
[2] Hubei Univ Med Shiyan, Renmin Hosp, Dept Cardiol, Shiyan 442000, Hubei, Peoples R China
[3] Peoples Hosp Dongxihu Dist, Dept Orthoped, 81 Ring Mt Rd, Wuhan 430040, Hubei, Peoples R China
关键词
cancer; genetics; polymorphism; heme oxygenase-1; meta-analysis;
D O I
10.3892/br.2018.1048
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Numerous studies have focused on the association between heme oxygenase-1 (HO-1) gene promoter polymorphisms and susceptibility to cancer; however, results remain ambiguous. The present systematic Human Genome Epidemiology review and meta-analysis aimed to clarify this association. A systematic search was used to assess the association of HO-1 gene polymorphisms with cancer susceptibility in the PubMed, Web of Science, Cochrane Library, Wanfang Data and China National Knowledge Infrastructure databases, with all reviewed studies published before April 10, 2017. Review Manager 5.3 and Stata 12.0 software were used to perform the meta-analysis. A total of 14 studies were included in the analysis. Overall, no significant associations of the HO-1 (GT) n and T(-413) A polymorphisms with cancer susceptibility were identified. However, subgroup analyses by ethnicity and cancer type indicated that the LL and L-allele (LL+LS) genotypes of HO-1 (GT) n were associated with increased susceptibility to cancer compared with the SS+SL and SS genotypes in the following subgroups: East Asian [LL+LS vs. SS: odds ratio (OR)=1.51, 95% confidence interval (CI)=1.11-2.05, P=0.0003; LL vs. SS+SL: OR=1.44, 95% CI=1.04-2.01, P=0.03; LL vs. SS: OR=1.64, 95% CI=1.07-2.52, P=0.02]; squamous cell carcinoma (LL+LS vs. SS: OR= 1.78, 95% CI=1.35-2.34, P<0.05; LL vs. SS+SL: OR=1.71, 95% CI=1.34-2.18, P<0.05; LL vs. SS: OR=2.26, 95% CI=1.62-3.14, P<0.05); and digestive tract cancer + East Asian (LL+LS vs. SS: OR=1.56, 95% CI=1.22-1.98, P<0.05; LL vs. SS: OR=1.80, 95% CI=1.06-3.05, P<0.05). These findings indicated that there was no association of the HO-1 (GT) n and T(-413) A polymorphisms with cancer susceptibility, while the L-allele genotypes (LL and LS) of HO-1 (GT) n may be susceptibility factors for cancer in East Asian, digestive tract cancer in East Asian and squamous cell carcinoma populations. Due to limitations of the reviewed studies, additional large-scale and refined studies are now required to confirm the present findings.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 43 条
  • [1] No Association between HMOX1 and Risk of Colorectal Cancer and No Interaction with Diet and Lifestyle Factors in a Prospective Danish Case-Cohort Study
    Andersen, Vibeke
    Kopp, Tine Iskov
    Tjonneland, Anne
    Vogel, Ulla
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (01) : 1375 - 1384
  • [2] Heme oxygenase-1 polymorphism is not associated with risk of colorectal cancer: a Danish prospective study
    Andersen, Vibeke
    Christensen, Jane
    Overvad, Kim
    Tjonneland, Anne
    Vogel, Ulla
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (03) : 282 - 285
  • [3] Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer
    Bouchet, D
    Chauveau, C
    Roussel, JC
    Mathieu, P
    Braudeau, C
    Tesson, L
    Soulillou, JP
    Iyer, S
    Buelow, R
    Anegon, I
    [J]. TRANSPLANT IMMUNOLOGY, 2002, 9 (2-4) : 235 - 238
  • [4] Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers
    Chang, KW
    Lee, TC
    Yeh, WI
    Chung, MY
    Liu, CJ
    Chi, LY
    Lin, SC
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1551 - 1555
  • [5] Heme oxygenase-1: emerging target of cancer therapy
    Chau, Lee-Young
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
  • [6] Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation
    Coppede, Fabio
    [J]. CANCER LETTERS, 2014, 342 (02) : 238 - 247
  • [7] New Insights into Intracellular Locations and Functions of Heme Oxygenase-1
    Dunn, Louise L.
    Midwinter, Robyn G.
    Ni, Jun
    Hamid, Hafizah A.
    Parish, Christopher R.
    Stocker, Roland
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (11) : 1723 - 1742
  • [8] Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagus
    Ghadban, T.
    Miro, J. T.
    Trump, F.
    Tsui, T. Y.
    Uzunoglu, F. G.
    Reeh, M.
    Gebauer, F.
    Bachmann, K.
    Wellner, U.
    Kalinin, V.
    Pantel, K.
    Izbicki, J. R.
    Vashist, Y. K.
    [J]. CLINICAL GENETICS, 2016, 90 (04) : 343 - 350
  • [9] Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis
    Hadzijusufovic, Emir
    Rebuzzi, Laura
    Gleixner, Karoline V.
    Ferenc, Veronika
    Peter, Barbara
    Kondo, Rudin
    Gruze, Alexander
    Kneidinger, Michael
    Krauth, Maria-Theresa
    Mayerhofer, Matthias
    Samorapoompichit, Puchit
    Greish, Khaled
    Lyer, Arun K.
    Pickl, Winfried F.
    Maeda, Hiroshi
    Willmann, Michael
    Valent, Peter
    [J]. EXPERIMENTAL HEMATOLOGY, 2008, 36 (11) : 1461 - 1470
  • [10] Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer
    Hong, Chi-Chen
    Ambrosone, Christine B.
    Ahn, Jiyoung
    Choi, Ji-Yeob
    McCullough, Marjorie L.
    Stevens, Victoria L.
    Rodriguez, Carmen
    Thun, Michael J.
    Calle, Eugenia E.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (09) : 1784 - 1794